A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitals

Infect Control Hosp Epidemiol. 2021 Sep;42(9):1082-1089. doi: 10.1017/ice.2020.1372. Epub 2021 Mar 19.

Abstract

Objective: In the era of widespread resistance, there are 2 time points at which most empiric prescription errors occur among hospitalized adults: (1) upon admission (UA) when treating patients at risk of multidrug-resistant organisms (MDROs) and (2) during hospitalization, when treating patients at risk of extensively drug-resistant organisms (XDROs). These errors adversely influence patient outcomes and the hospital's ecology.

Design and setting: Retrospective cohort study, Shamir Medical Center, Israel, 2016.

Patients: Adult patients (aged >18 years) hospitalized with sepsis.

Methods: Logistic regressions were used to develop predictive models for (1) MDRO UA and (2) nosocomial XDRO. Their performances on the derivation data sets, and on 7 other validation data sets, were assessed using the area under the receiver operating characteristic curve (ROC AUC).

Results: In total, 4,114 patients were included: 2,472 patients with sepsis UA and 1,642 with nosocomial sepsis. The MDRO UA score included 10 parameters, and with a cutoff of ≥22 points, it had an ROC AUC of 0.85. The nosocomial XDRO score included 7 parameters, and with a cutoff of ≥36 points, it had an ROC AUC of 0.87. The range of ROC AUCs for the validation data sets was 0.7-0.88 for the MDRO UA score and was 0.66-0.75 for nosocomial XDRO score. We created a free web calculator (https://assafharofe.azurewebsites.net).

Conclusions: A simple electronic calculator could aid with empiric prescription during an encounter with a septic patient. Future implementation studies are needed to evaluate its utility in improving patient outcomes and in reducing overall resistances.

MeSH terms

  • Adult
  • Anti-Infective Agents*
  • Hospitals
  • Humans
  • ROC Curve
  • Retrospective Studies
  • Sepsis* / drug therapy

Substances

  • Anti-Infective Agents